Evaluation of Vascular Endothelial Growth Factor A and Selected Parameters of Coagulation and Fibrinolysis in a Group of Patients with Subarachnoid Haemorrhage

Table 1

Comparison of VEGF-A concentrations in SAH patients and control group. Comparison of the concentrations of VEGF-A, depending on the gender, on the age and the prevalence of diabetes of patients with subarachnoid haemorrhage.

Parameter	Patients with SAH (n=85)		Control group (n=45)
	Me	Q1; Q3	Me	Q1; Q3	p
VEGF-A [ng/mL]	43,39	30,71	63,31	54,59	0,0008
				71,39
		67,48
Parameter	Men (n=38)		Women (n=47)
	Me	Q1; Q3	Me	Q1; Q3	p
VEGF-A [ng/mL]	46,74	31,11	40,78	27,14	ns
		67,74		65,88
Parameter	Age < 50 (n=34)		Age > 50 (n=51)
	Me	Q1; Q3	Me	Q1; Q3	p
VEGF-A [ng/mL]	42,64	30,71	43,39	27,80	ns
		71,02		65,88